Press release
Nonerosive Reflux Disease Treatment Market Segments, Dynamics, Treatment Agents Current Trends and Challenges Forecast - Global Review 2018 to 2026
Fact.MR
Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=1098
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease. Proton pump inhibitors (PPI) are therapeutically most efficient drugs in nonerosive reflux disease treatment though complete symptom control is low. H2 – blockers have low success rate in nonerosive reflux treatment but are having high usage. Reduced success rate of proton pump inhibitors in patients with GERD and heartburn is attributed to co-existing nonerosive reflux disease. Success of antireflux surgery in nonerosive reflux disease treatment is low when compared to erosive reflux disease. Antacids, Proton pump inhibitors and H2 – blockers are used in nonerosive reflux disease treatment and in case of chronic cases antireflux surgery is done.
The global nonerosive reflux disease treatment market is classified on the basis of product type, distribution channel and region
Based on the drug type nonerosive reflux disease treatment market is segmented into following:
• Proton pump inhibitors
• H2 – blockers
• Antacids
• Prokinetics
Request TOC of this Report@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1098
Based on the distribution channel nonerosive reflux disease treatment market is segmented into following:
• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
On the basis of geography, global nonerosive reflux disease treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Region wise North America is most lucrative market due increased prevalence of gastroesophageal reflux disease (GERD) and heartburn. Health related lifestyle correlating to obesity in North America is responsible for increasing nonerosive reflux disease treatment market and is only expected to grow. Nonerosive reflux disease is most common in patients with GERD and prevalence of gastroesophageal reflux disease (GERD) in North America (20%), Europe (9-17%) Asia Pacific (2-5%) once a week which is further responsible for nonerosive reflux disease treatment.
Key major players in the nonerosive reflux disease treatment market are: AstraZeneca plc, Eisai Co, GlaxoSmithKline PLC; Takeda Pharmaceutical Co., Ltd, Johnson & Johnson, Daewoong Pharmaceutical Co., Ltd.; Ironwood Pharmaceuticals, Inc.; SRS Pharmaceuticals Pvt. Ltd.; and SFJ Pharmaceuticals Group
The report covers exhaustive analysis on:
• Nonerosive reflux disease treatment Market Segments
• Nonerosive reflux disease treatment Market Dynamics
• Historical Actual Market Size, 2013 - 2017
• Nonerosive reflux disease treatment Market Size & Forecast 2018 to 2024
• Nonerosive reflux disease treatment Agents Current Trends/Issues/Challenges
• Competition & Companies involved
• Nonerosive reflux disease treatment Market Drivers and Restraints
Ask From the Experts@ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1098
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market Research Reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonerosive Reflux Disease Treatment Market Segments, Dynamics, Treatment Agents Current Trends and Challenges Forecast - Global Review 2018 to 2026 here
News-ID: 1143964 • Views: …
More Releases from Fact.MR
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083
The demand for dry powder inhalers is expected to rise due to the…
Global ISO Certification Market is projected to expand at a CAGR of 15.2% from 2 …
According to a recently released Fact.MR analysis, the global market for ISO certification is expected to be valued at US$ 16.14 billion by 2024. By the end of 2034, revenue from ISO certification is expected to grow at a 15.2% compound annual growth rate and reach a market valuation of US$ 66.25 billion.
In order to prove compliance with environmental, quality, or information security rules, a variety of sectors require ISO…
Gluten-free Bakery Products Market is expected to grow at a CAGR of 9.8% from 20 …
The gluten-free bakery products market is a dynamic sector influenced by various factors such as consumer dietary preferences, health trends, and advancements in food technology. As awareness of celiac disease and gluten sensitivities grows, so does the demand for gluten-free alternatives in baked goods.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3035
Gluten is a protein fraction generated from wheat, rye, barley, oats, and their derivatives and hybrids. It is an essential part…
Pet Grooming Services Market is projected to expand at a CAGR of 7.2% from 2024 …
The global pet grooming services market is anticipated to rise at a compound annual growth rate (CAGR) of 7.2%, from a value of US$ 3.3 billion in 2024 to US$ 6.7 billion by the end of 2034, according to the most recent market research analysis published by Fact.MR.
Pets are now considered members of the family by many. Pet owners want the best for their furry pals, just as much as…
More Releases for Nonerosive
Nonerosive Reflux Disease Treatment Market 2031 Report Enlightening Development …
The research report presents a market assessment of the Nonerosive Reflux Disease Treatment market and contains thoughtful insights, facts, and historical data and statistically supported and industry-validated market data
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry
250 page market research report by Fact.MR, ( leading business and competitive intelligence provider),…
Nonerosive Reflux Disease Treatment Market Information, Figures and Analytical I …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market Shares, Strategies and Forecast World …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Emerging Opportunities in Nonerosive Reflux Disease Treatment Market with Curren …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market to Reap Excessive Revenues by 2018 to …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market: Outlook, Opportunity and Demand Anal …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
